Drug Price Trends for IBUPROFEN-FAMOTIDIN

Average Pharmacy Cost for IBUPROFEN-FAMOTIDIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
IBUPROFEN-FAMOTIDIN 800-26.6 MG	67877-0626-90	0.87581	EACH	2025-03-19
IBUPROFEN-FAMOTIDIN 800-26.6 MG	70748-0312-09	0.87581	EACH	2025-03-19
IBUPROFEN-FAMOTIDIN 800-26.6 MG	31722-0315-90	0.87581	EACH	2025-03-19
IBUPROFEN-FAMOTIDIN 800-26.6 MG	49884-0366-09	0.87581	EACH	2025-03-19
IBUPROFEN-FAMOTIDIN 800-26.6 MG	49884-0366-09	0.85162	EACH	2025-02-19
IBUPROFEN-FAMOTIDIN 800-26.6 MG	31722-0315-90	0.85162	EACH	2025-02-19

Market Analysis and Price Projections for Ibuprofen-Famotidine

Introduction

Ibuprofen-famotidine, a combination drug, is gaining significant attention in the pharmaceutical market due to its dual action in managing symptoms of rheumatoid arthritis, osteoarthritis, and reducing the risk of upper gastrointestinal (GI) ulcers associated with ibuprofen use. Here’s a comprehensive analysis of the market and price projections for this drug.

Market Size and Growth

The global ibuprofen market, which includes ibuprofen-famotidine combinations, is projected to experience substantial growth. By 2031, the ibuprofen market is expected to reach USD 111.41 million, growing at a CAGR of 2.40% from 2024 to 2031[1].

However, when considering the broader ibuprofen market, including all formulations, the growth rate is more robust. The market is anticipated to be worth around USD 205.6 million by 2033, growing at a CAGR of 7.8% from 2024 to 2033[3].

Application Segments

Ibuprofen-famotidine is primarily used for:

• Rheumatoid Arthritis and Osteoarthritis: This segment is expected to hold the largest revenue share due to the increasing demand for effective analgesic and anti-inflammatory treatments[1].
• NSAID-Induced Ulcer Prophylaxis: The combination of ibuprofen and famotidine is specifically approved to decrease the risk of developing upper GI ulcers in patients taking ibuprofen for rheumatoid arthritis and osteoarthritis[4].

Geographical Analysis

The North American market dominates the global ibuprofen market, including ibuprofen-famotidine combinations. This region's strong healthcare expenditure, significant investment in healthcare infrastructure, and rising awareness of pain management contribute to its leading position[1][3].

Price Projections and Cost Factors

Current Pricing

The cost of ibuprofen-famotidine, under the brand name Duexis, can be substantial. For a supply of 90 tablets (26.6 mg-800 mg), the cost is around $857.80, depending on the pharmacy and any available discounts or coupons[2].

Factors Influencing Cost

• Treatment Plan: The cost varies based on the dosage and duration of treatment.
• Insurance Coverage: Insurance plans can significantly reduce the out-of-pocket cost.
• Pharmacy: Prices can differ between pharmacies.
• Generic vs. Brand Name: Generic versions, if available, tend to be less expensive than brand-name versions[5].

Budget Impact

A study on the budget impact of single-tablet ibuprofen-famotidine showed that while the initial medication cost is high ($734,192 over three years for a health plan of 1 million enrollees), it can be offset by reductions in other NSAID use, GI-protective agents, and GI complications. This results in a modest financial impact on total healthcare costs[4].

Competitive Landscape

The market for ibuprofen-famotidine is competitive, with several key players in the pharmaceutical industry. The presence of major manufacturers and a robust distribution network in regions like North America contributes to the drug's accessibility and market growth[1][3].

Opportunities and Challenges

Opportunities

• Emerging Markets: Increased healthcare awareness and rising disposable incomes in emerging markets present significant growth opportunities.
• Innovations in Drug Delivery: Advancements in drug delivery systems, such as sustained-release formulations, can enhance patient compliance and drive market growth[3].

Challenges

• Regulatory Scrutiny: Strict regulatory frameworks and approval processes can pose challenges to the introduction of new ibuprofen-famotidine products.
• Cost and Accessibility: High costs and varying insurance coverage can affect the drug's accessibility, especially for those without comprehensive insurance plans[3][5].

Key Drivers

• Increasing Chronic Pain Conditions: The growing prevalence of chronic pain conditions such as rheumatoid arthritis and osteoarthritis drives the demand for ibuprofen-famotidine.
• Efficacy and Safety: The drug's effectiveness in managing pain and reducing GI risks contributes to its market growth[1][3].

Regional Market Performance

North America leads in the ibuprofen market, including ibuprofen-famotidine combinations, due to its strong healthcare infrastructure and high healthcare spending. Other regions, such as Europe and Asia-Pacific, also show significant growth potential[1][3].

Patient Assistance and Copay Programs

While specific patient assistance programs for ibuprofen-famotidine may not be widely available, patients can often benefit from general discount cards, coupons, and copay programs that reduce the out-of-pocket cost of the medication[2][5].

Highlight

"The expected decrease in treatment costs for less serious GI-related complications illustrates the benefits of single-tablet ibuprofen/famotidine as a gastroprotective therapy in patients receiving chronic NSAID treatment, with a modest financial impact on total health care costs."[4]

Key Takeaways

• The ibuprofen-famotidine market is expected to grow significantly, driven by increasing chronic pain conditions and the drug's efficacy.
• North America dominates the market due to high healthcare spending and infrastructure.
• The cost of ibuprofen-famotidine can be substantial but is offset by reductions in other healthcare costs.
• Emerging markets and innovations in drug delivery systems offer growth opportunities.

FAQs

1. What is the primary use of ibuprofen-famotidine?

Ibuprofen-famotidine is primarily used to manage symptoms of rheumatoid arthritis and osteoarthritis, and to decrease the risk of developing upper gastrointestinal (GI) ulcers in patients taking ibuprofen.

2. How much does ibuprofen-famotidine cost?

The cost of ibuprofen-famotidine (Duexis) can be around $857.80 for a supply of 90 tablets, depending on the pharmacy and any available discounts or coupons.

3. What factors influence the cost of ibuprofen-famotidine?

The cost is influenced by the treatment plan, insurance coverage, pharmacy, and whether a generic version is available.

4. Which region dominates the ibuprofen-famotidine market?

North America dominates the market due to its strong healthcare infrastructure and high healthcare spending.

5. Are there patient assistance programs available for ibuprofen-famotidine?

While specific patient assistance programs for ibuprofen-famotidine may not be widely available, patients can benefit from general discount cards, coupons, and copay programs.

Sources

1. Verified Market Research: Ibuprofen Market Size, Share, Scope, Trends, Growth & Forecast.
2. Drugs.com: Famotidine/ibuprofen Prices, Coupons, Copay Cards & Patient Assistance.
3. Market.us: Ibuprofen Market Size, Share, Growth | CAGR Of 7.8%.
4. PubMed: Budget impact modeling for a single-tablet formulation of ibuprofen/famotidine.
5. MedicalNewsToday: Famotidine cost 2024: Coupons and more.